申请人:Takeda Pharmaceutical Company Limited
公开号:EP1803709A1
公开(公告)日:2007-07-04
A proton pump inhibitor containing a compound represented by the formula (I)
wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R2, R3 and R4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R5 and R6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.
一种质子泵抑制剂,含有由式 (I) 代表的化合物
其中 X 和 Y 相同或不同,并且各自是键或在主链中具有 1 至 20 个碳原子的间隔物,R1 是任选取代的烃基或任选取代的杂环基,R2、R3 和 R4 相同或不同,并且各自是氢原子、任选取代的烃基、任选取代的噻吩基、任选取代的苯并[b]噻吩基、任选取代的呋喃基、任选取代的吡啶基、任选取代的吡唑基、任选取代的嘧啶基、酰基、卤素原子、氰基或硝基,R5 和 R6 相同或不同,且各自为氢原子或任选取代的烃基,在体内转化为质子泵抑制剂后具有优异的质子泵作用并显示出抗溃疡活性等,或其盐。或其原药。